Do-Coop
Technologies Announces New Distribution Program. Establishes sales
channels for its expanding Neowater™ - Enhancer product line.
Released on
= May 5, 2005, 4:21 am
Press Release
Author = Addi Amirav
Industry = Healthcare
Press Release
Summary = Do-Coop Technologies Ltd., a privately held corporation
based in Israel, announced today the launching of its new world-wide
Distribution Program.
Press Release
Body = Do-Coop Technologies Announces New Distribution Program.
Establishes sales channels for its expanding Neowater™ - Enhancer
product line.
Do-Coop Technologies
Ltd., a privately held corporation based in Israel, announced today
the launching of its new world-wide Distribution Program.
Do-Coop Technologies
manufactures a stable system of largely hydrated nano-particles
(Neowater™) for the Life Sciences. Among the recently introduced
products we highlight Neowater™ - PCR Enhancer, Neowater™
- Transfection Enhancer, and Neowater™
- Transfection Enhancer. Do-Coop’s family of products, all
based on Do-Coop’s proprietary Neowater™ technology,
dramatically enhances existing reagents,
applications and processes to help segments of the Life Sciences
industry to achieve the results they expect and need. Today.
About Neowater™
Neowater™-based products consist of a stable system of largely
hydrated nano-particles that lead to several important benefits
for research, diagnostics and
bio-pharma applications. The hydrated nano-particles, like non-ionic
detergent derived micelles, reduce the entropy of aqueous solutions
and mimic intracellular
water. In addition, by design, they exhibit hydrophobic properties.
The non-ionic
Neowater™ works by coating components at their molecular level,
thus exposing, increasing and/or enhancing those specific surfaces
which are required for a specific reaction but are normally not
available to interact (e.g. GC-rich DNA).
Therefore, very small volumes of Neowater™, and reduced component’s
concentrations or amounts, are needed for a reaction when using
Neowater™. Neowater™ allows for (low-volume) miniaturization
of Life Sciences products, applications and processes.
Neowater™-based
products significantly accelerate and improve the efficiency of
biological reactions.
New Distribution
Program
“Following an initial period of customer validation for our
products, and the introduction of some unique products for the Research
and Diagnostic markets,
Do-Coop Technologies is in the process of establishing a network
of distributors to market its Neowater(TM)-based product line. Initially
we will be marketing our Neowater Enhancer family of products, followed
by a new line of Neowater-based Reagents and Neowater-based Diagnostic
Kits,” said Eran Gabbai, founder and CTO of Do-Coop Technologies,
and the inventor of Neowater™.
“We are in the process of introducing a complete product line
that dramatically enhances upstream research and diagnostic processes.
Our future plans include the introduction of novel downstream products
such as protein expression and purification enhancers, all of which
are based on Neowater™ technology,” he added.
Please visit
Do-Coop’s web site for Neowater technology and product information
at
www.docoop.com.
From: Ahead Business Solutions Ltd.
On Behalf of:
Do-Coop Technologies Ltd.
Email: info@docoop.com
http://www.docoop.com/
Web Site = http://www.docoop.com/
Contact Details
= Ahead Business Solutions Ltd.
25 Manchester Square London
addia@ahead-bs.com
Printer
Friendly Format
Back to previous
page...
Back to home page...
Submit your
press releases...
|
2012
